6
Oct
2026

GAP S.A.

Exhibitor at CPHI Milan 2026 stand 8C26, Contract Manufacturing & Services
About Us

GAP is  vertically integrated Greek pharmaceutical company operating   under EUGMP HACCP from 1949.
GAP operates in the following business units:   
1. Softgel capsules Contract Manufacture (Rx, OTC, hormonal, food supplements)
2. Development, manufacture of innovative Generic formulations 3. Development, manufacture and promotion of Nutraceuticals, under our EVIOL brand or under private label.

  • Country/Region:
    Greece
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 8C26, Contract Manufacturing & Services

Products Featured at CPHI Milan 2026

  • Vitamin D3 soft caps (Pharma/ OTC)

    Product Vitamin D3 soft caps (Pharma/ OTC)

    We have developed and offer under License and Supply Vitamin D3 soft gelatin capsules. Dossier is in eCTD format with WEU Strenghths: 800IU, 1.000IU, 3200IU, 5600U, 20.000IU,25.000IU 50.000IU
  • Calcium &  Vitamin D3  Chewable tablet

    Product Calcium & Vitamin D3 Chewable tablet

    Strengths:
    500 mg / 400 IU
    1000 mg / 800 IU

    Indication:
    Prevention and treatment of calcium and vitamin D deficiency & osteoporosis treatment


  • Innovative Food Supplements

    Product Innovative Food Supplements

    GAP offer its own brand for Food Supplements for Distribution or Pvt LabelOur formulas developed are ALL based on EFSA claims and cover many therapeutical categories: (ex. Mental Health, Sleep Disorders, Boosting Imune System etc)



    For full range please refer of the formulas we offer please g...
  • Tadalafil soft caps

    Product Tadalafil soft caps

    GAP specialises in innovative generics. GAP has developed TADALAFIL in soft caps offering unique marketing opportunities compared to standard generics in tablets.

    Indications:Genito-urinary System Erectile dysfunction
    Only 5 mg: benign prostatic dysfunction
    Only 20 mg: treat pulmon...
  • Isotretinoin soft caps

    Product Isotretinoin soft caps

    GAP is offering for out licence ISOTRETINOIN soft caps 5-10-20-40mg with the most updated BE study (2018) 

    GAP manufacturers per year over 250 milion caps of Isotretinoin Product is offered  for licensing or contract manufacture  agreement

GAP S.A. Resources (1)